0       0

AST 2014 - Cutting Edge of Transplantation


FR02b - Mesenchymal Stem Cells: Are These the Stem Cells We Were Looking For?


Feb 14, 2014 11:00am ‐ Feb 14, 2014 11:30am

Description

After years of anecdotal reports, mesenchymal stem cells have been used in a sizeable randomized controlled trial and shown to improve early outcomes. In addition to decreasing rejection through anti-inflammatory effects, such cells may aid repair and reduce injury – improving initial function. New studies using these cells to treat subclinical rejection and reduce ischemia reperfusion injury are in progress.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content